The invention discloses a
triptolide self-dissolving microneedle. According to the present invention in parts by weight, the tip matrix prescription of the
triptolide self-dissolving microneedle is 24-29 parts of PVP, 7.8-8.3 parts of PVA, 0.45-0.65 parts of CMC-Na, 0.28-0.42 parts of
triptolide 40-45 parts of
distilled water and 20-23 parts of absolute
ethanol; the backing layer matrix prescription of the triptolide self-dissolving microneedles is 32-37 parts of PVP, 9-12 parts of PVA and 53-58 parts of
distilled water. The present invention has good moldability and
mechanical strength of the microneedle, RSD value of the
drug loading is 0.98%, and the process is stable and feasible. The tip of the
drug-loaded microneedle can make most of the
drug reach the body quickly and take effect quickly. In addition, the microneedle matrix The sustained release effect of triptolide can improve the drug safety of triptolide, and reduce the expression and increase of
inflammatory factors TNF-ɑ, IL-17, PGE2, IgG, IgM, and IgA by reducing the
inflammatory infiltration of cells in the synovium. The expression of OPG, the trend of decreased
RANKL expression and the
RANKL / OPG ratio, realize the therapeutic advantages for
rheumatoid arthritis.